JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.960
+0.100 (5.38%)
At close: Mar 27, 2026

HKG:2126 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7951,0185189081,7415,333
Market Cap Growth
-6.47%96.55%-42.92%-47.87%-67.36%-47.83%
Enterprise Value
527717-7-461012,831
Last Close Price
1.962.511.282.264.3513.44
PS Ratio
2.523.233.084.7410.57141.07
PB Ratio
1.281.650.420.490.651.56
P/TBV Ratio
1.962.510.830.851.052.20
EV/Sales Ratio
1.672.27--0.6174.89
Debt / Equity Ratio
0.470.470.360.190.120.05
Net Debt / Equity Ratio
-0.43-0.43-0.29-0.41-0.47-0.60
Net Debt / EBITDA Ratio
0.490.490.871.411.762.29
Net Debt / FCF Ratio
--1.001.691.812.66
Asset Turnover
0.210.210.080.070.050.01
Inventory Turnover
2.372.372.452.292.431.35
Quick Ratio
1.281.281.663.854.579.31
Current Ratio
1.451.451.744.044.789.53
Return on Equity (ROE)
-64.37%-64.37%-41.40%-38.04%-32.89%-22.58%
Return on Assets (ROA)
-26.33%-26.33%-14.99%-14.43%-14.75%-13.99%
Return on Capital Employed (ROCE)
-94.80%-94.80%-37.80%-30.30%-28.10%-26.40%
Earnings Yield
-77.72%-60.69%-121.33%-93.23%-54.95%-16.17%
FCF Yield
---69.57%-49.87%-39.85%-14.60%
Buyback Yield / Dilution
-0.18%-0.18%-0.51%-0.35%-2.59%-203.07%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.